{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:29:14Z","timestamp":1772778554862,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007265","name":"Boston University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["2 R01 AI040944"],"award-info":[{"award-number":["2 R01 AI040944"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.vaccine.2018.10.074","type":"journal-article","created":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T22:16:52Z","timestamp":1540765012000},"page":"7689-7699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant"],"prefix":"10.1016","volume":"36","author":[{"given":"Munir","family":"Mosaheb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6596-2986","authenticated-orcid":false,"given":"Lee M.","family":"Wetzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.10.074_b0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","article-title":"Vaccine adjuvants: putting innate immunity to work","volume":"33","author":"Coffman","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.10.074_b0010","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/nm1209","article-title":"Vaccines: past, present and future","volume":"11","author":"Plotkin","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2018.10.074_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.inf.0000148933.08301.02","article-title":"Six revolutions in vaccinology","volume":"24","author":"Plotkin","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2018.10.074_b0020","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0025","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/171.6.1387","article-title":"Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum","volume":"171","author":"Robbins","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.074_b0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.1995.tb44439.x","article-title":"Prevention of systemic infections caused by group B streptococcus and Staphylococcus aureus by multivalent polysaccharide-protein conjugate vaccines","volume":"754","author":"Robbins","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2018.10.074_b0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-1-4899-1382-1_22","article-title":"Hypothesis: how licensed vaccines confer protective immunity","volume":"397","author":"Robbins","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2018.10.074_b0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1574-6976.2000.tb00530.x","article-title":"Vaccines, coming of age after 200 years","volume":"24","author":"Makela","year":"2000","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2018.10.074_b0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ni.2039","article-title":"Immunological mechanisms of vaccination","volume":"12","author":"Pulendran","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0055","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ni0304-233","article-title":"HIV vaccine design and the neutralizing antibody problem","volume":"5","author":"Burton","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/35021239","article-title":"Vaccines against intracellular infections requiring cellular immunity","volume":"406","author":"Seder","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.10.074_b0065","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2004.00138.x","article-title":"Progress in DNA-based heterologous prime-boost immunization strategies for malaria","volume":"199","author":"Moore","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2018.10.074_b0070","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1073\/pnas.0307158101","article-title":"A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses","volume":"101","author":"Prieur","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2018.10.074_b0075","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/nm1212","article-title":"T cell vaccines for microbial infections","volume":"11","author":"Robinson","year":"2005","journal-title":"Nat Med"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2018.10.074_b0080","doi-asserted-by":"crossref","first-page":"C25","DOI":"10.1016\/j.vaccine.2010.07.021","article-title":"Unmet needs in modern vaccinology: adjuvants to improve the immune response","volume":"28","author":"Leroux-Roels","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.074_b0085","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.cellimm.2005.08.020","article-title":"Expression of toll-like receptors on B lymphocytes","volume":"236","author":"Dasari","year":"2005","journal-title":"Cell Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0090","doi-asserted-by":"crossref","first-page":"13766","DOI":"10.1073\/pnas.250476497","article-title":"The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors","volume":"97","author":"Ozinsky","year":"2000","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2018.10.074_b0095","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/intimm\/13.7.933","article-title":"Discrimination of bacterial lipoproteins by Toll-like receptor 6","volume":"13","author":"Takeuchi","year":"2001","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0100","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.4049\/jimmunol.174.5.2942","article-title":"Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88","volume":"174","author":"Hasan","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0105","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2217\/fmb.10.41","article-title":"Innate immune function of the neisserial porins and the relationship to vaccine adjuvant activity","volume":"5","author":"Wetzler","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0110","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1128\/CVI.00125-08","article-title":"Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia","volume":"15","author":"Chiavolini","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0115","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.4049\/jimmunol.172.4.2431","article-title":"Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity","volume":"172","author":"Latz","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0120","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1086\/314966","article-title":"The role of B\/T costimulatory signals in the immunopotentiating activity of neisserial porin","volume":"180","author":"Mackinnon","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.074_b0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fimmu.2017.00225","article-title":"Toll-Like receptor ligand-based vaccine adjuvants require intact MyD88 signaling in antigen-presenting cells for germinal center formation and antibody production","volume":"8","author":"Mosaheb","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0130","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pep.2005.04.021","article-title":"Improved purification of native meningococcal porin PorB and studies on its structure\/function","volume":"44","author":"Massari","year":"2005","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2018.10.074_b0135","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.4049\/jimmunol.176.4.2373","article-title":"Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling","volume":"176","author":"Massari","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0140","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.4049\/jimmunol.153.9.4029","article-title":"Systemic cytokine profiles in BALB\/c mice immunized with trivalent influenza vaccine containing MF59 oil emulsion and other advanced adjuvants","volume":"153","author":"Valensi","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0145","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.vaccine.2007.11.080","article-title":"The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant","volume":"26","author":"Liu","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.074_b0150","doi-asserted-by":"crossref","first-page":"e82171","DOI":"10.1371\/journal.pone.0082171","article-title":"In Vivo and In Vitro characterization of the immune stimulating activity of the neisserial porin PorB","volume":"8","author":"Platt","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.10.074_b0155","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.4049\/jimmunol.168.4.1528","article-title":"Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses","volume":"168","author":"Foulds","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0160","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.4049\/jimmunol.162.7.3790","article-title":"Naive human CD4+ T cells are a major source of lymphotoxin alpha","volume":"162","author":"Ohshima","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0165","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1084\/jem.167.3.937","article-title":"Production of tumor necrosis factor\/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody","volume":"167","author":"Sung","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.10.074_b0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1084\/jem.188.2.247","article-title":"T cell receptor (TCR) engagement leads to activation-induced splicing of tumor necrosis factor (TNF) nuclear pre-mRNA","volume":"188","author":"Yang","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.10.074_b0175","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0180","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0952-7915(92)90084-R","article-title":"Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta)","volume":"4","author":"Ruddle","year":"1992","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0185","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/1097-0029(20000801)50:3<196::AID-JEMT3>3.0.CO;2-9","article-title":"Role of TNF in lymphocyte-mediated cytotoxicity","volume":"50","author":"Smyth","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.vaccine.2018.10.074_b0190","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1152\/advan.00066.2013","article-title":"T cell responses: naive to memory and everything in between","volume":"37","author":"Pennock","year":"2013","journal-title":"Adv Physiol Educ"},{"key":"10.1016\/j.vaccine.2018.10.074_b0195","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2217\/imt.11.100","article-title":"Naive, effector and memory CD8 T-cell trafficking: parallels and distinctions","volume":"3","author":"Nolz","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.vaccine.2018.10.074_b0200","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41598-017-00555-4","article-title":"The TLR2 binding neisserial porin PorB enhances antigen presenting cell trafficking and cross-presentation","volume":"7","author":"Reiser","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2018.10.074_b0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61779-325-7_1","article-title":"Unique strengths of ELISPOT for T cell diagnostics","volume":"792","author":"Lehmann","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0210","doi-asserted-by":"crossref","DOI":"10.3791\/3076","article-title":"Measuring bacterial load and immune responses in mice infected with Listeria monocytogenes","author":"Wang","year":"2011","journal-title":"J Visual Exp: JoVE."},{"key":"10.1016\/j.vaccine.2018.10.074_b0215","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nbt1207-1361","article-title":"Bridging the knowledge gaps in vaccine design","volume":"25","author":"Rappuoli","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.imlet.2005.08.002","article-title":"(How) do aluminium adjuvants work?","volume":"102","author":"Brewer","year":"2006","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2018.10.074_b0225","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.4049\/jimmunol.174.6.3545","article-title":"Neisserial porin-induced dendritic cell activation is MyD88 and TLR2 dependent","volume":"174","author":"Singleton","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00225","article-title":"Toll-Like receptor ligand-based vaccine adjuvants require intact MyD88 signaling in antigen-presenting cells for germinal center formation and antibody production","volume":"8","author":"Mosaheb","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0235","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.4049\/jimmunol.175.8.5043","article-title":"Rapid production of TNF-alpha following TCR engagement of naive CD8 T cells","volume":"175","author":"Brehm","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0240","first-page":"93","article-title":"Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages\/neutrophils: protective and deleterious effects","volume":"22","author":"Grivennikov","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.10.074_b0245","doi-asserted-by":"crossref","first-page":"721","DOI":"10.4049\/jimmunol.173.2.721","article-title":"Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells","volume":"173","author":"Xu","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0250","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T cell function","volume":"317","author":"Groom","year":"2011","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.vaccine.2018.10.074_b0255","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature08511","article-title":"CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help","volume":"462","author":"Nakanishi","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.10.074_b0260","doi-asserted-by":"crossref","first-page":"e56855","DOI":"10.1371\/journal.pone.0056855","article-title":"TRIF is required for TLR4 mediated adjuvant effects on T cell clonal expansion","volume":"8","author":"Gandhapudi","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.10.074_b0265","doi-asserted-by":"crossref","first-page":"e104814","DOI":"10.1371\/journal.pone.0104814","article-title":"Increased generation of HIV-1 gp120-reactive CD8+ T cells by a DNA vaccine construct encoding the chemokine CCL3","volume":"9","author":"Oynebraten","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.10.074_b0270","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0275","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04651","article-title":"Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction","volume":"440","author":"Castellino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.10.074_b0280","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/ni1495","article-title":"Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses","volume":"8","author":"Hugues","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0285","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.matbio.2014.01.010","article-title":"Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury","volume":"35","author":"Moreth","year":"2014","journal-title":"Matrix Biol: J Int Soc Matrix Biol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0290","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/smim.1997.0065","article-title":"Functions of CD8 T-cell subsets secreting different cytokine patterns","volume":"9","author":"Mosmann","year":"1997","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0295","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/IR:36:1:101","article-title":"Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivector","volume":"36","author":"He","year":"2006","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2018.10.074_b0300","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.180.2.489","article-title":"Th2-like CD8+ T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection","volume":"180","author":"Maggi","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2018.10.074_b0305","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/1074-7613(95)90051-9","article-title":"Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines","volume":"2","author":"Sad","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.10.074_b0310","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/eji.1830270417","article-title":"Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity","volume":"27","author":"Sad","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0315","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.170.1.613","article-title":"IL-4-producing CD8+ T cells with a CD62L++(bright) phenotype accumulate in a subgroup of older adults and are associated with the maintenance of intact humoral immunity in old age","volume":"170","author":"Schwaiger","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0320","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/529197","article-title":"Biology of immune responses to vaccines in elderly persons","volume":"46","author":"Weinberger","year":"2008","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.vaccine.2018.10.074_b0325","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0952-7915(00)00112-6","article-title":"Immunity to Listeria infection","volume":"12","author":"Edelson","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0330","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.immuni.2009.04.020","article-title":"Opposing effects of TGF-beta and IL-15 cytokines control the number of short-lived effector CD8+ T cells","volume":"31","author":"Sanjabi","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2018.10.074_b0335","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.4049\/jimmunol.170.4.2053","article-title":"Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection","volume":"170","author":"Shedlock","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0340","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.4049\/jimmunol.169.10.5805","article-title":"Nonsecreted bacterial proteins induce recall CD8 T cell responses but do not serve as protective antigens","volume":"169","author":"Zenewicz","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0345","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/(SICI)1097-0169(200001)45:1<58::AID-CM6>3.0.CO;2-Y","article-title":"Listeria monocytogenes ActA protein interacts with phosphatidylinositol 4,5-bisphosphate in vitro","volume":"45","author":"Steffen","year":"2000","journal-title":"Cell Motil Cytoskelet"},{"key":"10.1016\/j.vaccine.2018.10.074_b0350","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/IAI.68.2.999-1003.2000","article-title":"Role of listeriolysin O in cell-to-cell spread of Listeria monocytogenes","volume":"68","author":"Gedde","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.10.074_b0355","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/B978-0-12-394590-7.00001-4","article-title":"Mechanisms and immunological effects of apoptosis caused by Listeria monocytogenes","volume":"113","author":"Carrero","year":"2012","journal-title":"Adv Immunol"},{"key":"10.1016\/j.vaccine.2018.10.074_b0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-394590-7.00009-9","article-title":"Studies with Listeria monocytogenes lead the way","volume":"113","author":"Unanue","year":"2012","journal-title":"Adv Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18314592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18314592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T13:12:42Z","timestamp":1694005962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18314592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":72,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0264410X18314592"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}